Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer.
about
Gene Therapy for Cardiovascular DiseaseFibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applicationsGene delivery technologies for cardiac applicationsNanoparticulate carriers for the treatment of coronary restenosisNitric oxide synthase modulates angiogenesis in response to tissue ischemiaIndocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques.Transgenic mouse models in angiogenesis and cardiovascular disease.TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A.Delivery of plasmid DNA to vascular tissue in vivo using catheter balloons coated with polyelectrolyte multilayers.Effects of local gene transfer of VEGF on neointima formation after balloon injury in hypercholesterolemic rabbits.Restenosis and gene therapy.Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?Therapeutic angiogenesis in critical limb and myocardial ischemia.The protective effect of Bcl-xl overexpression against oxidative stress-induced vascular endothelial cell injury and the role of the Akt/eNOS pathway.Development and use of gene transfer for treatment of cardiovascular disease.Gene therapy for cardiovascular angiogenesis.VEGF polymorphisms and severity of atherosclerosis.Functional behavior and gene expression of magnetic nanoparticle-loaded primary endothelial cells for targeting vascular stents.Metabolic and structural integrity of magnetic nanoparticle-loaded primary endothelial cells for targeted cell therapy.Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.1H-pyrrole-2,5-dione-based small molecule-induced generation of mesenchymal stem cell-derived functional endothelial cells that facilitate rapid endothelialization after vascular injury.Promoting vascular regeneration as an alternative to conventional angioplasty-based intervention.Carotid repair using autologous adipose-derived endothelial cells.Atherosclerotic plaque development and instability: a dual role for VEGF.Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase-independent pathway.The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice.Hypoxic regulation of VEGF, HIF-1(alpha) in coronary collaterals development.Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.Adenovirus-mediated transfer of VEGF into marrow stromal cells combined with PLGA/TCP scaffold increases vascularization and promotes bone repair in vivo.Angiogenesis in the atherosclerotic plaque.Healing arterial ulcers: Endothelial lining regeneration upon vascular denudation injury.Current developments in the tissue engineering of autologous heart valves: moving towards clinical use.Gene therapy for cerebrovascular disease.VEGF and restenosis: the rest of the story.Quantification of Adventitial Vasa Vasorum Vascularization in Double-injury Restenotic Arteries.Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.Tissue engineered heart valves: autologous cell seeding on biodegradable polymer scaffold.In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model.Neuropilin 1 expression in human aortas, coronaries and the main bypass grafts.Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model.
P2860
Q24791063-C67D296F-CC73-4E5F-B13F-4699B4C7AEEBQ26829998-2AE674D8-65C5-4C42-9043-0455735E688DQ26863362-63D5D6BC-FD22-4AA5-8A03-07DB986E0C59Q28220309-44D23514-7F7A-4505-A577-C6932D5920D3Q28508302-BDB13FF7-6179-4EFA-A067-106A2A38BF7FQ30472773-E08B57A4-5962-4ACF-9484-1162AE9AFD92Q33843594-72C7DE62-67E2-40EB-AFE6-9933045112BCQ34007727-4D4D05C6-4F5F-4710-A7DB-F2C3E8713E04Q34349030-E47E95DF-B700-472F-A2D9-882B23F4345CQ34429250-F3C3A799-1854-4572-A9F6-1C22422B0C05Q34452138-558B7D2A-DC81-468A-B120-EBF3E22209A6Q34482530-E898C513-1DE6-46AD-B80C-933242B7BA28Q34675242-0DF1C084-F7A6-41D3-BFDF-4548CD62CC9AQ35039014-D5CD50C5-1750-4FA9-9D85-AAA10FA5870CQ35087832-62CDA92A-EEC9-4233-951B-06DAE8A03BE3Q35164797-FC7CD50E-5F5C-4A68-B668-4739E274ED86Q35448592-E85E74CD-AB6E-43BF-BF5D-43630CC5DFE0Q35703384-E14C7124-F502-4CEC-9FE1-C7C477320E6AQ35731259-2F18A395-807E-4B5A-8F7A-BAF3DDA285FFQ35764395-C5843DC6-151C-4D00-BCBE-4F2E01FFC96CQ36067191-A6BEC212-A90A-4A86-A655-0548E58244F7Q36684479-34604818-E9BF-40AD-A365-91DD3EF51489Q37172734-F855BA90-2F6F-4AB8-8D8E-0BF30B047A6CQ37352918-B134A3A4-15C6-4A21-BE62-2E3194168500Q37383757-CE56C0C3-66E1-4C84-9982-0849E528B560Q37422588-71560C05-182A-4654-ADB9-3224640413E3Q37475907-35E2CB67-9F38-4D12-909D-A069992FF3CFQ37511128-77135F96-67B9-4B0D-8890-800890BD60C6Q37636817-855B2A86-54B9-4F66-B9A8-43433C7D3162Q37645436-57E44615-A7BD-46ED-89DC-48DFD8699D61Q38532954-C7285062-D33C-4907-928F-66F81F9245D5Q39803177-1B1AE885-BE49-43D2-9948-84C7AF9AD02DQ40825648-9239485A-CEA0-47ED-B1A3-15FC4575BF45Q42595441-81F1B293-4935-4317-90C5-E8EC787F6D43Q43081473-0A921E88-BA7B-470E-A63A-13FAE3A8BD99Q43602044-D9318935-3EB1-4224-B42B-1B2EF6CAFF9FQ43986472-08521AC7-56FA-4BB9-820C-2DD1C52BE635Q45032198-FB55C1E9-C275-4A0E-B95D-8244B8FCE3E2Q45864063-F8FBDB65-27BE-45A9-BE26-CF8C81BFE836Q45870003-EFB58440-A238-4D3F-8092-9794687565B2
P2860
Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Accelerated restitution of end ...... after phVEGF165 gene transfer.
@en
Accelerated restitution of end ...... after phVEGF165 gene transfer.
@nl
type
label
Accelerated restitution of end ...... after phVEGF165 gene transfer.
@en
Accelerated restitution of end ...... after phVEGF165 gene transfer.
@nl
prefLabel
Accelerated restitution of end ...... after phVEGF165 gene transfer.
@en
Accelerated restitution of end ...... after phVEGF165 gene transfer.
@nl
P2093
P1433
P1476
Accelerated restitution of end ...... after phVEGF165 gene transfer.
@en
P2093
P304
P356
10.1161/01.CIR.94.12.3291
P407
P577
1996-12-01T00:00:00Z